发明申请
US20040102518A1 N-benzoylureidocinnamic acid derivatives, processes for preparing them and their use
有权
![N-benzoylureidocinnamic acid derivatives, processes for preparing them and their use](/abs-image/US/2004/05/27/US20040102518A1/abs.jpg.150x150.jpg)
基本信息:
- 专利标题: N-benzoylureidocinnamic acid derivatives, processes for preparing them and their use
- 专利标题(中):N-苯甲酰基肉豆蔻酸衍生物,其制备方法及其应用
- 申请号:US10456570 申请日:2003-06-06
- 公开(公告)号:US20040102518A1 公开(公告)日:2004-05-27
- 发明人: Karl Schoenafinger , Elisabeth Defossa , Dieter Kadereit , Erich Von Roedern , Thomas Klabunde , Hans-Joerg Burger , Andreas Herling , Karl-Ulrich Wendt
- 申请人: Aventis Pharma AG
- 申请人地址: DE Frankfurt am Main
- 专利权人: Aventis Pharma AG
- 当前专利权人: Aventis Pharma AG
- 当前专利权人地址: DE Frankfurt am Main
- 优先权: DE10225635.7-42 20020607
- 主分类号: A61K031/277
- IPC分类号: A61K031/277 ; A61K031/195 ; C07C275/48 ; A61K031/17
摘要:
The invention relates to N-benzoylureidocinnamic acid derivatives and to their physiologically tolerated salts and physiologically functional derivatives. The invention thus relates to compounds of formula I, 1 in which the radicals have the given meanings, and to their physiologically tolerated salts and processes for preparing them. The compounds are, for example, suitable for use as antidiabetic agents.
摘要(中):
本发明涉及N-苯甲酰基肉毒杆菌酸衍生物及其生理上耐受的盐和生理功能衍生物。 因此,本发明涉及其中基团具有给定含义的式I化合物及其生理上耐受的盐及其制备方法。 化合物例如适合用作抗糖尿病药。